Ignite Creation Date:
2025-12-24 @ 1:56 PM
Ignite Modification Date:
2025-12-30 @ 9:43 PM
Study NCT ID:
NCT05046795
Status:
COMPLETED
Last Update Posted:
2024-11-01
First Post:
2021-09-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Revefenacin in Chinese Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease(COPD)
Sponsor:
Mylan Pharma UK Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
REV-3001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None